tiprankstipranks
Advertisement
Advertisement
Buy Rating on PHIO: Strong Early PH-762 Clinical Data and Solid Cash Runway Support Upside Potential
PremiumRatingsBuy Rating on PHIO: Strong Early PH-762 Clinical Data and Solid Cash Runway Support Upside Potential
5M ago
Phio Pharmaceuticals Boosts CEO Severance and Incentive Compensation
Premium
Company Announcements
Phio Pharmaceuticals Boosts CEO Severance and Incentive Compensation
6M ago
Phio Pharmaceuticals Reports Positive PH-762 Phase 1b Safety Results
Premium
Company Announcements
Phio Pharmaceuticals Reports Positive PH-762 Phase 1b Safety Results
6M ago
Phio Pharmaceuticals files to sell 11.76M shares of common stock for holders
PremiumThe FlyPhio Pharmaceuticals files to sell 11.76M shares of common stock for holders
9M ago
Phio Pharmaceuticals: Promising Clinical Results and Strong Financial Position Justify Buy Rating
Premium
Ratings
Phio Pharmaceuticals: Promising Clinical Results and Strong Financial Position Justify Buy Rating
9M ago
Phio Pharmaceuticals Exercises Warrants for $13.4 Million
Premium
Company Announcements
Phio Pharmaceuticals Exercises Warrants for $13.4 Million
9M ago
Phio Pharmaceuticals Reports Positive Phase 1b Trial Results
PremiumCompany AnnouncementsPhio Pharmaceuticals Reports Positive Phase 1b Trial Results
9M ago
Phio Pharmaceuticals Appoints New Lead Independent Director
Premium
Company Announcements
Phio Pharmaceuticals Appoints New Lead Independent Director
10M ago
Phio Pharmaceuticals Advances with Promising PH-762 Study for Skin Cancer
Premium
Company Announcements
Phio Pharmaceuticals Advances with Promising PH-762 Study for Skin Cancer
10M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100